Clinical trials: ACCUVEIN
Cannulation
A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique
1. This study will compare the first attempt success rate of cannulation in research participants randomized to using a new FDA approved AccuVein AV300 device for intravenous access with research participants randomized to…
- Trial name
- NCT01042613
- Testing
- Cannulation using Accuvein device, Standard Cannulation method
- Where
- United States
- Volunteers
- 146 people
- Sponsor
- St. Jude Children's Research Hospital
Pediatric Disorder
A Comparison of Accuvein to Standard IV Access in Children 0 to 24 Months of Age in the Pediatric ED
Obtaining intravenous (IV) access in children under the age of 2 years is difficult, especially in the emergency department (ED) where the children can be frightened, dehydrated and ill.
- Trial name
- NCT02381392
- Testing
- Accuvein AV400
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Procedural Complication
A Comparison of the First Attempt Success Rate of Cannulation Between the Accuvein Apparatus and Standard Technique
Background: The AccuVein AV300 device helps in venepuncture and intravenous (IV) cannulation. It uses infrared light that can be absorbed by the blood hemoglobin so that veins location is clearly viewed on the skin's surface.
- Trial name
- NCT03462745
- Testing
- AccuVein AV 300
- Volunteers
- 184 people
- Sponsor
- American University of Beirut Medical Center